TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Shanghai Junshi Biosciences Co., Ltd. Class H ( (HK:1877) ) is now available.
Shanghai Junshi Biosciences Co., Ltd. has completed the registration of its First Grant of A Share Options under the 2025 A Share Option Incentive Scheme, following shareholder approval. The scheme involves 24,700,000 A Share Options granted to 226 participants, including employees and a substantial shareholder, with specific vesting and exercise conditions outlined for the options. This initiative is expected to enhance stakeholder engagement and align employee interests with company growth objectives.
The most recent analyst rating on (HK:1877) stock is a Sell with a HK$20.00 price target. To see the full list of analyst forecasts on Shanghai Junshi Biosciences Co., Ltd. Class H stock, see the HK:1877 Stock Forecast page.
More about Shanghai Junshi Biosciences Co., Ltd. Class H
Shanghai Junshi Biosciences Co., Ltd. is a joint stock company incorporated in China, operating within the biosciences industry. The company focuses on developing innovative therapeutic solutions, primarily through its bioscience research and development initiatives.
Average Trading Volume: 8,094,121
Technical Sentiment Signal: Buy
Current Market Cap: HK$38.64B
See more data about 1877 stock on TipRanks’ Stock Analysis page.